Orphenadrine citrate and Vitamins drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Orphenadrine citrate (orphenadrine citrate) and Vitamins (ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e). Common drug interactions include urticaria among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Orphenadrine citrate and Vitamins. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.

What is Orphenadrine citrate?

Orphenadrine citrate has active ingredients of orphenadrine citrate. It is often used in muscle aches. eHealthMe is studying from 1,189 Orphenadrine citrate users. Check the latest studies of Orphenadrine citrate.

What is Vitamins?

Vitamins has active ingredients of ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e. It is often used in vitamin supplementation. eHealthMe is studying from 122,456 Vitamins users. Check the latest studies of Vitamins.



On Jul, 18, 2026

27 people who take Orphenadrine citrate and Vitamins together, and have interactions are studied.

Orphenadrine citrate and Vitamins drug interactions.

What are the common drug interactions of Orphenadrine Citrate and Vitamins, by gender? *:

female:

  1. Urticaria (rash of round, red welts on the skin that itch intensely)
  2. Vomiting
  3. Headache (pain in head)
  4. Nausea (feeling of having an urge to vomit)
  5. Diarrhoea
  6. Fall
  7. Migraine (headache)
  8. Abdominal discomfort
  9. Abdominal pain
  10. Acute myocardial infarction (acute heart attack)

male:

  1. Anxiety
  2. Fall
  3. Pain
  4. Respiratory failure (inadequate gas exchange by the respiratory system)
  5. Septic shock (shock due to blood infection)
  6. Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream)
  7. Anaemia (lack of blood)
  8. Arteriovenous fistula thrombosis (formation of a blood clot inside a blood vessel-av fistula)
  9. Renal failure (kidney dysfunction)
  10. Abdominal distension

What are the common drug interactions of Orphenadrine Citrate and Vitamins, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Urticaria (rash of round, red welts on the skin that itch intensely)
  2. Vomiting
  3. Asthma
  4. Carpal tunnel decompression
  5. Drug hypersensitivity
  6. Drug ineffective
  7. Flushing (the warm, red condition of human skin)
  8. Nausea (feeling of having an urge to vomit)
  9. Osteopenia (a condition where bone mineral density is lower than normal)
  10. Pruritus (severe itching of the skin)

50-59:

  1. Anxiety
  2. Pain
  3. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  4. Chronic kidney disease
  5. Emotional distress
  6. Renal failure (kidney dysfunction)
  7. Abdominal distension
  8. Alpha 1 foetoprotein decreased
  9. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  10. Arthralgia (joint pain)

60+:

  1. Fall
  2. Headache (pain in head)
  3. Anaemia (lack of blood)
  4. Arteriovenous fistula thrombosis (formation of a blood clot inside a blood vessel-av fistula)
  5. Diarrhoea
  6. Nausea (feeling of having an urge to vomit)
  7. Abdominal discomfort
  8. Abdominal pain
  9. Acute myocardial infarction (acute heart attack)
  10. Arthritis bacterial (form of joint disorder that involves inflammation of one or more joints due to bacterial infection)

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 7 people, 25.93%
  2. Hiv Infection: 3 people, 11.11%
  3. Osteoporosis (bones weak and more likely to break): 2 people, 7.41%
  4. Ill-Defined Disorder: 2 people, 7.41%

* Approximation only. Some reports may have incomplete information.

Do you take Orphenadrine citrate and Vitamins?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Orphenadrine citrate and Vitamins:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Orphenadrine citrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Vitamins:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Orphenadrine citrate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vitamins and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on orphenadrine citrate and ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e (the active ingredients of Orphenadrine citrate and Vitamins, respectively), and Orphenadrine citrate and Vitamins (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: